88
Views
2
CrossRef citations to date
0
Altmetric
Review

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective

, , , &
Pages 391-399 | Published online: 23 Oct 2014

References

  • JhaVCurrent status of end-stage renal disease care in India and PakistanKidney Int Suppl20133157160
  • GuptaRSankheSDobbsRWoetzelJMadgavkarAHasyagarAIndia’s path from poverty to empowerment [webpage on the Internet]New York, NYMcKinsey Global Institute Available from: http://www.mckinsey.com/insights/asia-pacific/indias_path_from_poverty_to_empowermentAccessed September 9, 2014
  • ModiGJhaVIncidence of ESRD in IndiaKidney Int20117957321321559
  • RajapurkarMMJohnGTKirpalaniALWhat do we know about chronic kidney disease in India: first report of the Indian CKD RegistryBMC Nephrol2012131022390203
  • JelokaTKUpaseSChitikeshiSMonthly cost of three sessions a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patientsIndian J Nephrol201222394122279341
  • kizlerTADietary protein restriction in CKD: the debate continuesAm J Kidney Dis200953218919119166797
  • MenonVKoppleJDWangXEffect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyAm J Kidney Dis200953220821718950911
  • LeveyASGreeneTSarnakMJEffect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyAm J Kidney Dis200648687988817162142
  • WagnerCANovel insights into the regulation of systemic phosphate homeostasis and renal phosphate excretionJ Nephrol20072013013417514616
  • GolubEEBiomineralization and matrix vesicles in biology and pathologySemin Immunopathol20113340941721140263
  • MurerHForsterIBiberJThe sodium phosphate cotransporter family SLC34Pflugers Arch200444776376712750889
  • MarksJDebnamESUnwinRJThe role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney diseaseCurr Opin Nephrol Hypertens201322448148723666413
  • MichigamiTRegulation and disorders of calcium and phosphate metabolismClin Calcium201424216917524473349
  • ManghatPSodiRSwaminathanRPhosphate homeostasis and disordersAnn Clin Biochem Epub2282014
  • WahlPWolfMFGF23 in chronic kidney diseaseAdv Exp Med Biol201272810712522396166
  • PavoneVTestaGGioitta IachinoSHypophosphatemic rickets: etiology, clinical features and treatmentEur J Orthop Surg Traumatol Epub6242014
  • KestenbaumBSachsMCHoofnagleANFibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of AtherosclerosisCirc Heart Fail20147340941724668259
  • QuarlesDReducing cardiovascular mortality in chronic kidney disease: something borrowed, something newJ Clin Invest2013123254254323298840
  • FliserDKolleritsBNeyerUFibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) StudyJ Am Soc Nephrol20071892600260817656479
  • SalibaWEl-HaddadBSecondary hyperparathyroidism: pathophysiology and treatmentJ Am Board Fam Med200922557458119734404
  • HruskaKAMathewSLundRHyperphosphatemia of chronic kidney diseaseKidney Int200874214815718449174
  • LishmanovADorairajanSPakYElevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney diseaseInt Urol Nephrol201244254154721327525
  • EddingtonHKalraPAThe association of chronic kidney disease-mineral bone disorder and cardiovascular riskJ Ren Care201036Suppl 1616720586901
  • SpragueSMRenal bone diseaseCurr Opin Endocrinol Diabetes Obes201017653553921030840
  • AlfreyACThe role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcificationKidney Int Suppl200490S13S1715296502
  • BrancaccioDCozzolinoMGallieniMHyperparathyroidism and anemia in uremic subjects: a combined therapeutic approachJ Am Soc Nephrol200415Suppl 1S21S2414684666
  • RodriguezMLorenzoVParathyroid hormone, a uremic toxinSemin Dial200922436336819708982
  • CozzolinoMDussoASSlatopolskyERole of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failureJ Am Soc Nephrol2001122511251611675430
  • HujairiNMAfzaliBGoldsmithDJCardiac calcification in renal patients: what we do and don’t knowAm J Kidney Dis20044323424314750088
  • BrandenburgVMSinhaSSpechtPKettelerMCalcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorderPediatr Nephrol Epub1292014
  • BlockGAHulbert-ShearonTELevinNWPortFKAssociation of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: a national studyAm J Kidney Dis1998316076179531176
  • GaneshSKStackAGLevinNWHulbert-ShearonTPortFKAssociation of elevated serum PO(4), Ca PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patientsJ Am Soc Nephrol2001122131213811562412
  • RufinoMGarcíaSJiménezAHeart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its preventionKidney Int Suppl200385S115S11812753280
  • CozzolinoMBrancaccioDGallieniMSlatopolskyEPathogenesis of vascular calcification in chronic kidney diseaseKidney Int200568242943616014020
  • JakobyMG4thSemenkovichCFThe role of osteoprogenitors in vascular calcificationCurr Opin Nephrol Hypertens200091111510654819
  • ThadhaniRAppelbaumEPritchettYVitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trialJAMA2012307767468422337679
  • BlockGAWheelerDCPerskyMSEffects of phosphate binders in moderate CKDJ Am Soc Nephrol20122381407141522822075
  • National Kidney FoundationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseAm J Kidney Dis2003424 Suppl 3S114520607
  • RussoDMirandaIRuoccoCThe progression of coronary artery calcification in pre-dialysis patients on calcium carbonate or sevelamerKidney Int2007721255126117805238
  • MallucheHHRitzELangeHPBone histology in incipient and advanced renal failureKidney Int19769355362940274
  • CoburnJWKoppelMHBrickmanASMassrySGStudy of intestinal absorption of calcium in patients with renal failureKidney Int197332642724600294
  • BurnettS-AGunawardeneSBringhurstFRJuppnerHLeeHFinkelsteinJSRegulation of C-terminal and intact FGF-23 by dietary phosphate in men and womenJ Bone Miner Res2006211187119616869716
  • CollinsAJKasiskeBHerzogCExperts from the United States Renal Data System 2004 annual data report: atlas of end stage renal disease in the United StatesAm J Kidney Dis200545S1S280
  • RamirezJAEmmettMWhiteMGThe absorption of dietary phosphorus and calcium in hemodialysis patientsKidney Int1986307537593784305
  • LeiXGPorresJMPhytase enzymology, applications, and biotechnologyBiotechnol Lett2003251787179414677699
  • SullivanCSayreSSLeonJBEffect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trialJAMA200930162963519211470
  • SullivanCMLeonJBSehgalARPhosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patientsJ Ren Nutr20071735035417720105
  • Food and Nutrition BoardPhosphorusDietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and FluorideInstitute of MedicineWashington, DCNational Academy Press1997146189
  • AlfreyACLegendreGRKaehnyWDDialysis encephalopathy syndrome: possible aluminum intoxicationsN Engl J Med19762941841881244532
  • HewittCDSavoryJWillsMRAspects of aluminum toxicityClin Lab Med1990104034222197055
  • EmmettMA comparison of clinically useful phosphorus binders for patients with chronic kidney failureKidney Int Suppl200490S25S3215296504
  • JamalSAVandermeerBRaggiPEffect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysisLancet2013382126823870817
  • FloegeFCovicACKettelerMA phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsKidney Int20148663864724646861
  • ReddyYAbrahamGReddyYMineral bone disease in maintenance hemodialysis patients: association with morbidity and mortalityIndian J Nephrol Epub cited July 13, 2014. Available from: http://www.indianjnephrol.org/preprintarticle.asp?id=132988Accessed September 9, 2104
  • AbrahamGKherVSaxenaSSevelamer carbonate experience in Indian end stage renal disease patientsIndian J Nephrol201222318919223087553
  • PaiABSheplerBMComparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implicationsPharmacotherapy200929555456119397463
  • ShanthaGPKumarAAManchaAIs abdominal aortic calcification score a cost-effective screening tool to predict atherosclerotic carotid plaque and cardiac valvular calcification in patients with end-stage renal disease?Indian J Nephrol201222643143723440913